If it works, ESCR7 could drastically change the way cancer is being treated around the world. Though it is yet to be sent for clinical trials before it can be released for commercial use, if it shows positive results, it can be used to annihilate 90 percent of all known cancers.

As a result, ESCR7 will not only be an important contribution to world medicine, but a source of hope for cancer patients all over the world.